DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Comi G, De Stefano N, Freedman MS. , et al.
Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial.
Lancet Neurol 2012;
11 (01) 33-41
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.